Dermatology

Pharma haircare market in India finds its growth roots in young patients

Growth more than twice that of overall dermatology market; September sales surge 37.1% year-on-year, driven largely by higher volumes

Aurobindo Pharma's Acrotech enters US dermatology market with Adquey launch

To support the launch and expand this therapeutic segment, the company has set up a dedicated dermatology business unit, the filing said.

World Vitiligo Day: How Michael Jackson brought global attention to vitiligo

Michael Jackson introduced millions to vitiligo, but the autoimmune disease remains widely misunderstood. On World Vitiligo Day, here's what causes it, how it affects people, and why awareness matters

Organised aesthetic clinics set to gain from tighter rules on Botox

CDSCO's move can lead to the formalisation of more than 35,000 skin clinics, stop the mushrooming of single-operator setups run by unqualified practitioners

Chosen raises $5 million to expand science-led skincare business

Fireside Ventures leads funding round with participation from L'Oreal's Bold and Alkemi Growth Capital as startup scales R&D, product pipeline for Indian skin needs

Heat, sweat, spend: The new summer skincare economy

India's harsh summers are turning skincare from a routine into a necessity, pushing consumers to spend more on protection, hydration and comfort in increasingly extreme weather conditions

Thinking of Botox before 30? What doctors say about benefits and risks

As Botox gains popularity among people in their 20s, experts examine whether early use truly prevents ageing and explain who may benefit, potential risks, and when it is best avoided

Does plucking a grey hair cause more? Dermatologist busts the myth

Many believe pulling out one grey hair will cause several more to grow. A dermatologist explains the science behind greying, and what really happens when you pull out that first silver strand

Five skincare red flags dermatologists say shoppers routinely overlook

From viral hype to '100% results' claims, dermatologists outline five subtle yet crucial red flags that often mislead shoppers into buying products that overpromise and underdeliver

Is your gymwear giving you a rash? It's more common than you think

Tight synthetics, sweat and chemicals in gymwear can trigger textile dermatitis, a skin allergy more common than most people realise, warn dermatologists

This is why dermatologists want you to stop wearing nail polish daily

Constant nail polish use may hide early signs of anaemia, diabetes or even cancer

Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn

Sun Pharma plans to leverage its global presence to accelerate patient access to this crucial treatment

Glenmark, Cosmo get MHRA nod to market acne treatment medication in UK

Glenmark Pharmaceuticals and Ireland-based Cosmo Pharmaceuticals NV have received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a product for the treatment of acne vulgaris in the United Kingdom. In a joint statement, the companies said they have received approval for Winlevi, a topical treatment for acne vulgaris in patients aged 12 years and older. As part of the agreement inked in September 2023, Glenmark in-licensed the product from Cosmo Pharmaceuticals for distribution in Europe and South Africa. "Our partnership with Cosmo Pharmaceuticals plays an important role in enabling us to expand our dermatology portfolio, and we are proud to offer this new treatment to market that can improve the quality of life for those living with acne," Glenmark Pharmaceuticals President & Business Head - Europe and Emerging Markets Christoph Stoller said. Cosmo CEO Giovanni Di Napoli said the milestone underscores the company's commitment, alongside ...

PUNE'S TOP DERMATOLOGIST: Viva Luxe by Dr. Sonnal Chavaan Expands to Baner

.

Dermatology segment in IPM poised for 11- 12% growth amid rising demand

The increasing incidence of skin diseases and the growing awareness about these conditions among the Indian populace have been pivotal in driving the dermatology market's expansion

Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore

The deal would enable Eris' entry into the Rs 3k cr injectables market, and it would become one of major players in the insulins segment with the acquisition of Biocon Biologic's Basalog and Insugen

Biocon to sell branded formulations biz to Eris Lifesciences for $150 mn

Biocon had earlier sold its dermatology and nephrology branded formulation businesses to Eris for Rs 350 crore in November last year

Glenmark, Pfizer launch Abrocitinib in India for Atopic Dermatitis

The prevalence of atopic dermatitis in India has risen over the past three decades, with approximately 5.9 per cent of adults affected, of which 4.4 per cent suffer from a severe form of the disease

Honasa Consumer's profit rises 93% to Rs 29.4 crore in September quarter

According to the firm's first-ever earnings update since its stock market debut earlier this month, consolidated revenue from operations grew 21 per cent Y-o-Y to Rs 496.1 crore

Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr

The business includes over 20 mother brands with revenue of Rs 90 crore in FY23 and the current run-rate is around Rs 100 crore